Active Chemical Compound : Body Protection Compound-157 (BPC-157) Industry Kit Designation : BPC-157 10mg (10mg Total Net Weight per Vial) Purity Threshold : 99.2% Verified via HPLC / Mass Spectrometry Physical State Form : Lyophilized White Powder (Vacuum Sealed Cake) Stabilizing Agent Matrix : Low-moisture Mannitol Excipient Base Regulatory Standing : Strictly for In Vitro and Laboratory Evaluation Only Chemical Profile and Mechanism of Action The BPC-157 peptide formulation consists of a pentadecapan peptide
MOTS-c is not FDA-approved and should be obtained and dosed only under the supervision of a licensed physician through a licensed compounding pharmacy
Benefits: collagen & elastin production, firmer skin, wound healing, reduced inflammation, and hair growth
The introduction of the R17 Cagri- E14 Cagri intra-peptide ionic lock energetically favours the formation of a predominant bypass conformation at the CTR, which, together with the P37 substitution and the effects induced by the N-terminal acylation, likely underlies its improved potency over rAmy at this receptor
Oncogene 26 (37), 53195328
